We are live on ! Find out more
SXTC icon

China SXT Pharmaceuticals
SXTC

4 hedge funds and large institutions have $131K invested in China SXT Pharmaceuticals in 2026 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 6 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

less capital invested

Capital invested by funds: $ → $
Holders
4
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$2.01M
2
+$205
3
+$26

Top Sellers

1
-$241K
2
-$137K
3
-$85.9K
4
XT
XTX Topco
Cayman Islands
-$36.4K
5
VF
Virtu Financial
New York
-$20K
Name Holding Trade Value Shares
Change 		Change in
Stake
SM
1
Sabby Management
Florida
$131K
UBS Group
2
UBS Group
Switzerland
$2
CIAM
3
Caitong International Asset Management
Hong Kong
$2
Citadel Advisors
4
Citadel Advisors
Florida
–
Invesco
5
Invesco
Georgia
–
Geode Capital Management
6
Geode Capital Management
Massachusetts
–
XT
7
XTX Topco
Cayman Islands
–
VF
8
Virtu Financial
New York
–
TRCT
9
Tower Research Capital (TRC)
New York
–
Royal Bank of Canada
10
Royal Bank of Canada
Ontario, Canada
–